Clinical Trial Update: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

Global pediatric/adolescent trial evaluating novel agents for relapsed and refractory B-cell non-Hodgkin lymphoma. The study is currently recruiting and include…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: University of Birmingham | Conditions: B-cell Non Hodgkin Lymphoma | Phase 2, Phase 3 | Status: RECRUITING